IGI · 1 day ago
Senior Director – Translational Sciences (Solid Tumor)
New York, United States
Full-time
Onsite
Director/Executive
10+ years expIGI, Inc. is a global biotechnology company focused on developing innovative biologics in oncology. The Senior Director of Translational Sciences will lead the translational strategy for solid tumor programs, bridging preclinical research and clinical application to drive therapeutic innovation.
BiotechnologyHealth CareOncologyProduct Research
Responsibilities
Define and execute translational strategies for solid tumor programs across the pipeline
Collaborate with discovery, clinical, regulatory, and commercial teams to align translational goals with program milestones
Lead identification, validation, and implementation of predictive, pharmacodynamic, and prognostic biomarkers
Oversee development of companion diagnostics in partnership with external vendors and internal stakeholders
Design and support early-phase clinical trials with robust translational endpoints
Interpret clinical biomarker data to inform patient selection and dose optimization
Stay abreast of emerging technologies and trends in tumor biology, immuno-oncology, and precision medicine
Foster external collaborations with academic institutions, consortia, and CROs
Qualification
Required
PhD, MD, or MD/PhD in oncology, molecular biology, immunology, or related field
10+ years of industry experience in translational sciences, with a strong focus on solid tumors
Proven track record of biomarker strategy development and clinical trial support
Deep understanding of tumor microenvironment, resistance mechanisms, and molecular profiling
Experience with regulatory submissions and companion diagnostic development
Strong leadership, communication, and cross-functional collaboration skills
Experience in immuno-oncology or targeted therapies
Familiarity with high-dimensional data (e.g., NGS, proteomics, single-cell analysis)
Prior involvement in IND-enabling studies and regulatory interactions
Company
IGI
IGI, Inc. is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology.
51-200 employees
H1B Sponsorship
IGI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
Funding
Current Stage
Growth StageLeadership Team
Cyril Konto
President, Chief Executive Officer and Board Director
Eugene Zhukovsky
Scientific Advisory Board member
Recent News
Pharma Letter
2025-07-12
2025-06-03
Company data provided by crunchbase